In this trial , 401 patients ( mean age 598 years [ SD 93 ] ; HbA1c 79 % [ 63 mmol/mol ] ; mean diabetes duration 126 years [ SD 80 ] ) were block randomised ( ratio 1:1 ) to receive either stepwise treatment or full basal-bolus treatment .